Hereditary papillary renal cell carcinoma Advocacy Hub | UniteRare

At a Glance

Live from database

Regulatory Watchboard

1 event

Apr 2025Study Evaluating the Efficacy and Safety of Darolutamide and Stereotactic Dose Escalated Radiotherapy in Patients With Localized Prostate Cancer and High-risk Features of Relapse

UNICANCER — PHASE3

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Hereditary papillary renal cell carcinoma.
Check the disease page for updates →

Clinical Trial Landscape

No active clinical trials currently recruiting for Hereditary papillary renal cell carcinoma.
Search all trials →

Search clinical trials for Hereditary papillary renal cell carcinoma →

Recent News & Research

No recent news articles indexed yet for Hereditary papillary renal cell carcinoma.
Search PubMed for Hereditary papillary renal cell carcinoma →

Browse all Hereditary papillary renal cell carcinoma news →

Specialist Network

Top 6 by expertise

Brenda Sandmaier

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

📍 SEATTLE, WA

Score 2917 trials

Elizabeth A Mullen

Children's Oncology Group

Score 244 trials

Ramaprasad Srinivasan, M.D

National Cancer Institute LAO

📍 BETHESDA, MD

Score 201 trial28 pubs

Ramaprasad Srinivasan, M.D., M.D

National Cancer Institute (NCI)

📍 BETHESDA, MD

Score 136 trials

W. Marston Linehan, M.D.

National Cancer Institute (NCI)

📍 Bethesda, Maryland

Score 116 trials

Vitaly Margulis, MD, MD

University of Texas Southwestern Medical Center

📍 DALLAS, TX

Score 52 trials

View all Hereditary papillary renal cell carcinoma specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰